Carregant...
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early oestrogen receptor positive breast cancer
AIM: Decisions regarding adjuvant chemotherapy for early breast cancer are complex. Ki67 is increasingly used, in conjunction with conventional prognostic markers, to help decide the use of adjuvant chemotherapy for early breast cancer. Ki67 has been proposed as an economical alternative to Oncotype...
Guardat en:
| Publicat a: | Asia Pac J Clin Oncol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8075631/ https://ncbi.nlm.nih.gov/pubmed/28960862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajco.12779 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|